Skip to content

The Effect of Probiotic Yogurt Containing Lactobacillus Rhamnosus and Bifidobacterium Bifidum on inflammatory factors in systemic lupus erythematosus- A triple-blind, randomized, and controlled trial

The Effect of Probiotic Yogurt Containing Lactobacillus Rhamnosus and Bifidobacterium Bifidum on inflammatory factors in systemic lupus erythematosus- A triple-blind, randomized, and controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240821062833N1
Enrollment
33
Registered
2024-08-31
Start date
2021-05-04
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SLE.

Interventions

Intervention group: Intervention group: Description of the intervention: 200 grams of plain yogurt, which is similar to the probiotic yogurt, should be consumed daily for 13 weeks..

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: age 20 – 60 years, SLEDAI =6, the body mass index (BMI) ranges from 25 to 40 kg/m2, following a stable medication regimen for the last three months

Exclusion criteria

Exclusion criteria: The exclusion criteria of the study included the use of the probiotic product 1 month before the study initiation, digestive tract disorders or lactose intolerance, inflammatory disease including (Pancreatitis, IBD, myocarditis, etc), kidney and liver diseases, food supplement consumption of at least one month before the intervention, smoking, lactating or pregnancy, changes in the dosage of drugs, consumption of alcoholic beverages, being on a weight-reduction diet.

Design outcomes

Primary

MeasureTime frame
Interferon alpha measurement - anti-dsDNA measurement - anti-RO measurement - ESR measurement - CRP measurement -. Timepoint: Before the intervention and 3 months later at the end of the study. Method of measurement: ELISA - chemiluminescence immunoassay method - ESR analyzer device - CRP US Kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRazieh banaki

Tehran University of Medical Sciences

r.banaki@gmail.com+98 21 8490 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026